Nephros (NEPH) Short Interest Ratio & Short Volume $1.88 +0.05 (+3.02%) Closing price 03:58 PM EasternExtended Trading$1.87 0.00 (-0.27%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nephros Short Interest DataNephros (NEPH) has a short interest of 11,400 shares, representing 0.12% of the float (the number of shares available for trading by the public). This marks a -45.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 12,403 shares to cover all short positions.Current Short Interest11,400 sharesPrevious Short Interest21,000 sharesChange Vs. Previous Month-45.71%Dollar Volume Sold Short$22,731.60Short Interest Ratio0.8 Days to CoverLast Record DateApril 15, 2025Outstanding Shares10,600,000 sharesFloat Size9,240,000 sharesShort Percent of Float0.12%Today's Trading Volume3,162 sharesAverage Trading Volume12,403 sharesToday's Volume Vs. Average25% Short Selling Nephros? Sign up to receive the latest short interest report for Nephros and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNEPH Short Interest Over TimeNEPH Days to Cover Over TimeNEPH Percentage of Float Shorted Over Time Nephros Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202511,400 shares $22,731.60 -45.7%0.1%0.8 $1.99 3/31/202521,000 shares $36,120.00 +8.3%0.2%1.4 $1.72 3/15/202519,400 shares $30,846.00 +133.7%0.2%1.4 $1.59 2/28/20258,300 shares $12,533.00 -13.5%0.1%0.6 $1.51 2/15/20259,600 shares $14,592.00 +92.0%0.1%0.7 $1.52 1/31/20255,000 shares $7,950.00 -30.6%0.1%0.5 $1.59 1/15/20257,200 shares $11,520.00 +67.4%0.1%0.8 $1.60 12/31/20244,300 shares $6,321.00 -12.2%0.1%0.5 $1.47 12/15/20244,900 shares $7,595.00 -36.4%0.1%0.4 $1.55 11/30/20247,700 shares $11,935.00 No Change0.1%0.7 $1.55 Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 11/15/20247,700 shares $12,012.00 -30.6%0.1%0.7 $1.56 10/31/202411,100 shares $16,095.00 +1,750.0%0.1%1 $1.45 10/15/2024600 shares $876.00 -76.9%0.0%0 $1.46 9/30/20242,600 shares $4,446.00 -25.7%0.0%0.2 $1.71 9/15/20243,500 shares $6,518.19 -23.9%0.0%0.3 $1.86 8/31/20244,600 shares $8,418.00 +119.1%0.1%0.4 $1.83 8/15/20242,100 shares $3,927.00 -30.0%0.0%0.2 $1.87 7/31/20243,000 shares $6,570.00 +76.5%0.0%0.2 $2.19 7/15/20241,700 shares $3,740.00 -55.3%0.0%0.1 $2.20 6/30/20243,800 shares $8,018.00 +52.0%0.0%0.3 $2.11 6/15/20242,500 shares $5,275.00 +316.7%0.0%0.2 $2.11 5/31/2024600 shares $1,308.00 -81.3%0.0%0 $2.18 5/15/20243,200 shares $6,560.00 +33.3%0.0%0.2 $2.05 4/30/20242,400 shares $5,448.00 +50.0%0.0%0.1 $2.27 4/15/20241,600 shares $3,184.00 -38.5%0.0%0.1 $1.99 3/31/20242,600 shares $5,694.00 +44.4%0.0%0.1 $2.19 3/15/20241,800 shares $3,906.00 -64.7%0.0%0.1 $2.17 2/29/20245,100 shares $16,116.00 +24.4%0.1%0.2 $3.16 2/15/20244,100 shares $14,391.00 -40.6%0.0%0.1 $3.51 1/31/20246,900 shares $24,495.00 -24.2%0.1%0.2 $3.55 1/15/20249,100 shares $31,213.00 -18.0%0.1%0.3 $3.43 12/31/202311,100 shares $38,406.00 -57.3%0.1%0.4 $3.46 12/15/202326,000 shares $74,880.00 -14.8%0.3%1.1 $2.88 11/30/202330,500 shares $69,845.00 +23.0%0.3%2.7 $2.29 11/15/202324,800 shares $51,336.00 +10.7%0.3%2.9 $2.07 10/31/202322,400 shares $36,957.76 -27.7%0.2%2.5 $1.65 10/15/202331,000 shares $50,840.00 +36.0%0.3%3.7 $1.64 9/30/202322,800 shares $33,744.00 -24.0%0.3%2.7 $1.48 9/15/202330,000 shares $42,600.00 -19.8%0.3%4.5 $1.42 8/31/202337,400 shares $61,336.00 -13.0%0.4%3.7 $1.64Altucher: Turn $900 into $108,000 in just 12 months? (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment… 8/15/202343,000 shares $64,930.00 +80.7%0.5%0.6 $1.51 7/31/202323,800 shares $32,844.00 -5.9%0.3%0.3 $1.38 7/15/202325,300 shares $35,420.00 -10.6%0.3%0.3 $1.40 6/30/202328,300 shares $43,865.00 -6.0%0.3%0.4 $1.55 6/15/202330,100 shares $44,849.00 +51.3%0.3%0.4 $1.49 5/31/202319,900 shares $31,840.00 +9.9%0.2%0.2 $1.60 5/15/202318,100 shares $22,697.40 -13.8%0.2%1.1 $1.25 4/30/202321,000 shares $29,820.00 -7.9%0.2%1.3 $1.42 4/15/202322,800 shares $32,376.00 -4.6%0.3%1.3 $1.42 3/31/202323,900 shares $25,570.61 +17.7%0.3%1.3 $1.07 3/15/202320,300 shares $20,503.00 -18.8%0.2%1 $1.01 2/28/202325,000 shares $27,250.00 +12.6%0.3%1.1 $1.09 2/15/202322,200 shares $29,304.00 +30.6%N/A0.8 $1.32 1/31/202317,000 shares $22,948.30 -32.5%N/A0.6 $1.35 1/15/202325,200 shares $29,736.00 +50.9%N/A0.9 $1.18 12/30/202216,700 shares $19,325.24 -51.2%N/A0.6 $1.16 12/15/202234,200 shares $37,339.56 +12.1%N/A1.2 $1.09 11/30/202230,500 shares $31,720.00 +64.0%N/A1.1 $1.04 11/15/202218,600 shares $19,768.08 -14.3%N/A0.3 $1.06 10/31/202221,700 shares $22,785.00 -35.6%N/A0.4 $1.05 10/15/202233,700 shares $38,418.00 +15.4%N/A0.6 $1.14 9/30/202229,200 shares $26,572.00 +15.0%0.3%0.5 $0.91 9/15/202225,400 shares $30,734.00 -52.3%0.3%0.4 $1.21 8/31/202253,200 shares $75,012.00 +51.1%0.6%1 $1.41 8/15/202235,200 shares $60,192.00 +2.3%0.4%1.5 $1.71 7/31/202234,400 shares $51,256.00 +5.2%0.4%0.7 $1.49 7/15/202232,700 shares $50,031.00 -22.5%N/A0.6 $1.53 6/30/202242,200 shares $64,566.00 +32.7%N/A0.9 $1.53 6/15/202231,800 shares $51,834.00 -37.7%N/A0.7 $1.63 5/31/202251,000 shares $94,350.00 +82.1%0.6%0.8 $1.85 5/15/202228,000 shares $57,400.00 No Change0.3%0.4 $2.05 4/30/202228,000 shares $111,440.00 +7.7%0.3%0.7 $3.98 4/15/202226,000 shares $117,520.00 -3.0%0.3%0.8 $4.52 3/31/202226,800 shares $117,920.00 -15.2%0.3%0.8 $4.40 3/15/202231,600 shares $122,924.00 +26.4%0.4%0.9 $3.89 2/28/202225,000 shares $113,250.00 -13.2%0.3%1 $4.53 2/15/202228,800 shares $139,680.00 +20.0%0.3%1.5 $4.85 1/31/202224,000 shares $110,880.00 +3.9%0.3%1.5 $4.62 1/15/202223,100 shares $121,275.00 +9.0%0.3%1.7 $5.25 12/31/202121,200 shares $125,080.00 +12.8%0.2%1.8 $5.90 12/15/202118,800 shares $132,916.00 +5.0%0.2%2.3 $7.07 11/30/202117,900 shares $124,405.00 +16.2%0.2%2.5 $6.95 11/15/202115,400 shares $115,500.00 -3.8%0.2%2.3 $7.50 10/29/202116,000 shares $125,440.00 +8.8%0.2%2.3 $7.84 10/15/202114,700 shares $114,072.00 -9.8%0.2%2 $7.76 9/30/202116,300 shares $142,951.00 -10.9%0.2%2.4 $8.77 9/15/202118,300 shares $163,785.00 +24.5%0.2%2 $8.95 8/31/202114,700 shares $120,687.00 +17.6%0.2%1.7 $8.21 8/13/202112,500 shares $99,000.00 -28.2%0.1%1.4 $7.92 7/30/202117,400 shares $145,464.00 +0.6%0.2%1.9 $8.36Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/15/202117,300 shares $156,046.00 -44.7%0.2%1.7 $9.02 6/30/202131,300 shares $317,657.44 +82.0%0.4%3 $10.15 6/15/202117,200 shares $154,800.00 +22.9%0.2%1.5 $9.00 5/28/202114,000 shares $122,500.00 +15.7%0.2%1.1 $8.75 5/14/202112,100 shares $97,042.00 No ChangeN/A0.9 $8.02 4/30/202112,100 shares $95,469.00 +3.4%N/A0.8 $7.89 4/15/202111,700 shares $90,090.00 +9.4%N/A0.7 $7.70 3/31/202110,700 shares $73,509.00 +18.9%N/A0.6 $6.87 3/15/20219,000 shares $67,590.00 -9.1%N/A0.5 $7.51 2/26/20219,900 shares $75,933.00 -20.8%N/A0.6 $7.67 2/12/202112,500 shares $106,875.00 +54.3%N/A0.6 $8.55 1/29/20218,100 shares $68,283.00 -8.0%N/A0.4 $8.43 1/15/20218,800 shares $70,400.00 -3.3%N/A0.6 $8.00 12/31/20209,100 shares $75,803.00 -18.0%N/A0.6 $8.33 12/15/202011,100 shares $82,029.00 +26.1%N/A0.7 $7.39 11/30/20208,800 shares $53,328.00 +23.9%N/A0.6 $6.06 11/15/20207,100 shares $44,446.00 -65.5%N/A0.5 $6.26 10/30/202020,600 shares $131,840.00 -7.6%N/A1.8 $6.40 10/15/202022,300 shares $148,072.00 +75.6%N/A1.9 $6.64 9/30/202012,700 shares $91,821.00 -26.2%N/A1 $7.23 9/15/202017,200 shares $121,260.00 +4.9%N/A1.4 $7.05 NEPH Short Interest - Frequently Asked Questions What is Nephros' current short interest? Short interest is the volume of Nephros shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,400 shares of NEPH short. 0.12% of Nephros' shares are currently sold short. Learn More on Nephros' current short interest. What is a good short interest ratio for Nephros? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NEPH shares currently have a short interest ratio of 1.0. Learn More on Nephros's short interest ratio. What is a good short interest percentage for Nephros? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of Nephros' floating shares are currently sold short. Is Nephros' short interest increasing or decreasing? Nephros saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 11,400 shares, a drop of 45.7% from the previous total of 21,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nephros' float size? Nephros currently has issued a total of 10,600,000 shares. Some of Nephros' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nephros currently has a public float of 9,240,000 shares. How does Nephros' short interest compare to its competitors? 0.12% of Nephros' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Nephros: iCAD, Inc. (1.04%), Microbot Medical Inc. (21.53%), FONAR Co. (0.28%), Sensus Healthcare, Inc. (6.46%), Fractyl Health, Inc. (13.57%), Inovio Pharmaceuticals, Inc. (18.34%), Zynex, Inc. (21.51%), Cytosorbents Co. (3.17%), IceCure Medical Ltd (0.80%), Vivani Medical, Inc. (1.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Nephros stock? Short selling NEPH is an investing strategy that aims to generate trading profit from Nephros as its price is falling. NEPH shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nephros? A short squeeze for Nephros occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NEPH, which in turn drives the price of the stock up even further. How often is Nephros' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEPH, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies iCAD Short Squeeze Microbot Medical Short Squeeze FONAR Short Squeeze Sensus Healthcare Short Squeeze Fractyl Health Short Squeeze Inovio Pharmaceuticals Short Squeeze Zynex Short Squeeze Cytosorbents Short Squeeze IceCure Medical Short Squeeze Vivani Medical Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NEPH) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NEPH Stock Free NEPH Stock Alerts